Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...
Novo’s treatments for obesity and diabetes headline the government’s list of medicines that will be subject to price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback